• A prognostic signature based on genes associated with m6A/m5C/m1A/m7G modifications and its immunological characteristics in clear cell renal cell carcinoma
• A Rare Case of Primary Vulval Amelanotic Melanoma Involving the Urethra
• A Scaled Proteomic Discovery Study for Prostate Cancer Diagnostic Markers Using Proteograph^TM and Trapped Ion Mobility Mass Spectrometry
• Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial
• Advancing bladder cancer management: development of a prognostic model and personalized therapy
• An integrated bioinformatic investigation of kallikrein gene family members in kidney renel cell carcinoma
• AP-2α gene deregulation is associated with renal cell carcinoma patient survival
• Artemisinin pre-treatment fore cisplatin dosage enhances high grade urothelial carcinoma treatment in male albino mice via reverse gene expression modulation of FGFR3, HRAS, P53 and KDM6A
• Artificial intelligence algorithm for neoplastic cell percentage estimation and its application to copy number variation in urinary tract cancer
• Asiaticoside enhances the effect of propofol on the invasion, ferroptosis and immune escape of bladder cancer
• Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab
• Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
• Bioinformatics analysis to disclose shared molecular mechanisms between type-2 diabetes and clear-cell renal-cell carcinoma, and therapeutic indications
• Cabazitaxel as a promising therapy for cisplatin-resistant bladder cancer: a preliminary study
• Canine primary ureteral leiomyosarcoma treated with unilateral left ureteronephrectomy
• Case report: response to immunotherapy and association with the fh gene in hereditary leiomyomatosis and renal cell cancer-associated renal cell cancer
• Central pathology review and its prognostic value in upper tract urothelial carcinoma patients: a nationwide multi-institutional study
• Clinical evolution of bladder carcinosarcoma: A case report and literature review
• Comparison of single-port versus multi-port robotic assisted partial nephrectomy: a systematic review and meta-analysis of perioperative and oncological outcomes
• Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker
• Construction of a 12-Gene Prognostic Risk Model and Tumor Immune Microenvironment Analysis Based on the Clear Cell Renal Cell Carcinoma Model
• Cryptotanshinone Inhibits Bladder Cancer Cell Malignant Progression in a Lipopolysaccharide-Induced Inflammatory Microenvironment through NLRP3 Inhibition
• Cutaneous leiomyosarcoma in a case of hereditary leiomyomatosis and renal cell carcinoma syndrome
• Deciphering the Effects of the PYCR Family on Cell Function, Prognostic Value, Immune Infiltration in ccRCC and Pan-Cancer
• Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer
• Differential effect of surgical technique on intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial cancer: a systematic review and Meta-analysis
• Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma
• DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes
• Do we need a re-TUR after en bloc resection of T1 stage bladder cancer?
• Enhancing the Efficacy of Radiomics-Based Prediction of Fuhrman Pathological Grading in Renal Clear Cell Carcinoma Using Multilayer Spiral CT Imaging
• Evaluating trophinin associated protein as a biomarker of prognosis and therapy response in renal cell carcinoma
• Exosomes in Renal Cell Cancer: Diagnostic and Therapeutic Nanovehicles
• Exploration of biomarkers for nursing physical examination early screening of multiple tumors
• Factors Associated with Outcomes at 1 Year in Paediatric Post-nephrectomy Patients for Nephroblastoma at the University Teaching Hospital and Cancer Diseases Hospital in Lusaka, Zambia
• Fc receptor-like A promotes malignant behavior in renal cell carcinoma and correlates with tumor immune infiltration
• Frequency of benign tumors after partial nephrectomy and the association between malignant tumor findings and preoperative clinical parameters
• Frequent gene mutations and the correlations with clinicopathological features in clear cell renal cell carcinoma: preliminary study based on Chinese population and TCGA database
• Functional outcomes in robot-assisted partial nephrectomy with three-dimensional images reconstructed from computed tomography: a propensity score-matched comparative analysis
• Genomic patterns of somatic mutations provide new prognostic, therapeutic, and biological insights in cancer
• Hexokinase HK3-mediated O-GlcNAcylation of EP300: a key regulator of PD-L1 expression and immune evasion in ccRCC
• Higher genetically predicted triglyceride level increases the bladder cancer risk independent of LDL and HDL levels
• Horseshoe kidney with teratoid type of Wilms tumor: a rare case report
• HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES
• Identification and Validation of Prognostic Model for Tumor Microenvironment-Associated Genes in Bladder Cancer Based on Single-Cell RNA Sequencing Data Sets
• Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target
• Immunogenomic profiles and therapeutic options of the pan-programmed cell death-related lncRNA signature for patients with bladder cancer
• Impact of diabetes mellitus on oncologic outcomes in patients receiving robot-assisted radical cystectomy for bladder cancer
• Impact of intra-tumoral immunity on predicting response and survival after neoadjuvant cisplatin-based chemotherapy in patients with muscle invasive bladder cancer
• Impact of tumor multiplicity on the prognosis of patients with primary renal cell carcinoma: a SEER database analysis
• Laparoscopic removal of retroperitoneal schwannoma in renal hilum: a case report
• Letter to the editor for the article "Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies"
• Long survivors after radical cystectomy versus healthy population: propensity score matched analysis of health-related quality of life
• Macrophages directly kill bladder cancer cells through TNF signaling as an early response to BCG therapy
• Mapping of Human Polyomavirus in Renal Cell Carcinoma Tissues
• Mixed epithelial and stromal tumor of the kidney: A case report in elderly male patient
• MMP-14 Exhibits Greater Expression, Content and Activity Compared to MMP-15 in Human Renal Carcinoma
• Molecular understanding and clinical aspects of tumor-associated macrophages in the immunotherapy of renal cell carcinoma
• Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancers
• Multiple omics integrative analysis identifies GARS1 as a novel prognostic and immunological biomarker: from pan-cancer to bladder cancer
• Nc-RNA-mediated low expression of AZIN1 correlated with unfavorable prognosis in kidney renal clear cell carcinoma
• Novel method for detecting frequent TERT promoter hot spot mutations in bladder cancer samples
• NRP1 knockdown inhibits the invasion and migration of rhabdoid tumor of the kidney cells
• On Entity Embeddings for Ordinal Features as Representation Learning in Recurrence Prediction of Urothelial Bladder Cancer
• On-clamp vs off-clamp robot-assisted partial nephrectomy for achieving modified trifecta: inverse probability of treatment weighting analysis from a high-volume tertiary robotic center
• Outcomes of open versus robotic partial nephrectomy: a 20-year single institution experience
• Patient-derived bladder cancer organoids show stable transcript expression along cultivation
• Perioperative and extended outcomes of patients undergoing parastomal hernia repair following cystectomy and ileal conduit
• Perioperative, functional and oncologic outcomes of percutaneous ablation versus minimally invasive partial nephrectomy for clinical T1 renal tumors: outcomes from a pooled analysis
• Potential utility of ADNP in circulating tumor cells as biomarker for prognostics in non-muscle-invasive bladder cancer
• Predicting prognosis and drug sensitivity in bladder cancer: an insight into Pan-programmed cell death patterns regulated by M6A modifications
• Predicting tumor mutation burden and VHL mutation from renal cancer pathology slides with self-supervised deep learning
• Prediction of non-muscle invasive bladder cancer recurrence using deep learning of pathology image
• Primary exophytic urothelial carcinoma of the bladder: A case report
• Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer
• Prostate ductal adenocarcinoma exhibiting a late recurrence in the anterior urethra 13 years post-total prostatectomy: a case report
• Quantitative ⁶⁸Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following ¹⁷⁷Lu-PSMA-617 (VISION Trial)
• Radiomics nomogram based on CT radiomics features and clinical factors for prediction of Ki-67 expression and prognosis in clear cell renal cell carcinoma: a two-center study
• Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis
• Renal and Urinary Conditions: Kidney Cysts and Tumors
• Renal angiomyolipoma rupture in the immediate postoperative period following caesarean section
• Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial
• Significance of Charlson co-morbidity index as predictive factor for post-op complications after radical nephrectomy
• Single-center analysis of a real-world cohort of patients with metastatic urothelial carcinoma evaluated by NGS: molecular landscape and efficacy of targeted therapies
• SUMO E3 ligase MUL1 inhibits lymph node metastasis of bladder cancer by mediating mitochondrial HSPA9 translocation
• Synergistic intravesical instillation for bladder cancer: CRISPR-Cas13a and fenbendazole combination therapy
• Targeted gene sequencing reveals disparate genomic mutations between young and older adults in renal cell carcinoma
• The clinical significance and anti-tumor role of PRKG1 in bladder cancer
• The effect of enhanced recovery after surgery (ERAS) in renal surgery
• The role of BUD31 in clear cell renal cell carcinoma: prognostic significance, alternative splicing, and tumor immune environment
• The urinary tract reconstruction in a robot-assisted surgery for rectal malignancy with combined prostate and seminal vesicle resection
• Three-dimensional imaging of upper tract urothelial carcinoma improves diagnostic yield and accuracy
• TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3
• Tranexamic acid reduces perioperative blood transfusions following open radical cystectomy - a propensity-score matched analysis
• Treatment Options for Signet Ring Cell Carcinoma of the Urinary Bladder: A Population-Based Study
• Unbiased discovery of cancer pathways and therapeutics using Pathway Ensemble Tool and Benchmark
• Unveiling the association between HMG-CoA reductase inhibitors and bladder cancer: a comprehensive analysis using Mendelian randomization, animal models, and transcriptomics
• Unveiling the unique role of TSPAN7 across tumors: a pan-cancer study incorporating retrospective clinical research and bioinformatic analysis
• Urachal and Nonurachal Adenocarcinomas of the Urinary Bladder: A Comprehensive Genomic Profiling Study
• Urinary Tract Cytopathology: Current and Future Impact on Patient Care
• Validation and Comparison of Prognostic Models in Renal Carcinoma in a Tertiary Hospital